April 18, 2022
Takeda’s TAKHZYRO® (lanadelumab-flyo) Prefilled Syringe Now Available for People With Hereditary Angioedema (HAE) Ages 12 Years and Older in the United States
April 12, 2022
Engitix Announces Expanded Collaboration and Licensing Agreement with Takeda to Develop New Anti-Fibrotic Therapies in Inflammatory Bowel Disease
January 10, 2022
Takeda Canada Launches Digital Health Innovation Challenge to Canada’s Inspiring Tech Community
No current content.